- In October 2023, QIAGEN achieved CE certification for its IVD kit and automated testing platform, NeuMoDx. This development significantly boosted the company’s revenue and market share
- In May 2023, Danaher Corporation introduced the Dxl 9000 Access Immunoassay Analyzer capable of processing up to 215 tests per hour. This launch expanded the company’s offerings in point-of-care diagnostics
- In May 2023, BD announced 510k clearance for its BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application, which incorporates AI software. This innovation reduces test result turnaround times by automating the labor-intensive process of identifying bacterial growth traditionally done using petri dishes
